BHVN Stock Analysis: Buy, Sell, or Hold?
BHVN - Biohaven Ltd.
$14.96
0.18 (1.22%)
▲
5d:
+23.74%
30d:
+58.31%
90d:
+78.31%
HOLD
MODERATE Confidence
Analysis Updated: Jun 24, 2026 12:00 AM ET
Earnings: Aug 10, 2026
Smart Money Distribution
None View Scanner →
Strength: 7.9/10
Get Alerted When BHVN Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD - EXTENDED: BHVN is 13.6% above its trading range ($13.17). Fundamentals are solid but entry is stretched. Hold existing positions; wait for pullback to add new shares.
📊 HOLD - EXTENDED: BHVN is 13.6% above its trading range ($13.17). Fundamentals are solid but entry is stretched. Hold existing positions; wait for pullback to add new shares.
In-depth Analysis How we analyze
Valuation Analysis: BHVN is currently trading at $14.96, which is considered extended relative to its 30-day fair value range of $9.48 to $13.17.
Technical Outlook: Technically, BHVN is in a downtrend. Immediate support is located at $10.86, while resistance sits at $15.80.
Market Sentiment: BHVN has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $21.71 (+46.9%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, BHVN is in a downtrend. Immediate support is located at $10.86, while resistance sits at $15.80.
Market Sentiment: BHVN has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $21.71 (+46.9%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$9.48 -
$13.17
Company Quality Score
57/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
52.6%
Protect Your Profits
BHVN is technically overbought (RSI 71). Consider hedging now to protect against a potential pullback while keeping your upside.
View Profit Protection PlanAll Signals
- BEARISH: Price significantly overextended (+13.6% above its trading range)
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 46.9% below Wall St target ($21.71)
Trading Range Analysis
30-Day Trading Range
$9.48 -
$13.17
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$10.86
Resistance Level
$15.80
Current Trend
Downtrend
Technical data as of
Jun 24, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-7.57
Wall Street Target
$21.71
(+46.9%)
Share & Embed Analysis
Last updated: June 24, 2026 4:44 PM ET
Data refreshes hourly during market hours. Next update: 5:44 PM
Data refreshes hourly during market hours. Next update: 5:44 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is BHVN showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ONC
BeiGene, Ltd. |
STRONG BUY
24 analysts |
$412 | 58 HOLD |
|
RARE
Ultragenyx |
STRONG BUY
20 analysts |
$52 | 59 HOLD |
|
AXSM
Axsome Therapeutics Inc |
STRONG BUY
19 analysts |
$276 | 59 HOLD |
|
VKTX
Viking Therapeutics Inc |
STRONG BUY
19 analysts |
$93 | 60 HOLD |
|
CRNX
Crinetics Pharmaceutical… |
STRONG BUY
17 analysts |
$83 | 60 BUY |
Advanced BHVN Option Strategies
Professional options setups generated by AI based on today's BHVN price and gamma walls.
